These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 15110955)

  • 1. [Current treatments of xerophthalmia in Sjögren's syndrome].
    Baudouin C; Pisella PJ; Brignole F
    Rev Med Interne; 2004 May; 25(5):376-82. PubMed ID: 15110955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic evaluation of diquafosol tetrasodium for the treatment of Sjögren's syndrome.
    Bremond-Gignac D; Gicquel JJ; Chiambaretta F
    Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):905-13. PubMed ID: 24797483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nonsteroidal anti-inflammatory agents: their topical use in the treatment of xerophthalmia secondary to Sjögren's syndrome].
    Giorgi D; Giorgi A; D'Angelo G; Verrastro G; Lai S; Grandinetti F; Gabrieli CB
    Recenti Prog Med; 1997 Sep; 88(9):397-400. PubMed ID: 9380944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic immunomodulatory therapy in severe dry eye secondary to inflammation.
    Cordero-Coma M; Anzaar F; Sobrin L; Foster CS
    Ocul Immunol Inflamm; 2007; 15(2):99-104. PubMed ID: 17558834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin Eye Drops Suppress Lacrimal Gland Inflammation In a Murine Model of Sjögren's Syndrome.
    Shah M; Edman MC; Reddy Janga S; Yarber F; Meng Z; Klinngam W; Bushman J; Ma T; Liu S; Louie S; Mehta A; Ding C; MacKay JA; Hamm-Alvarez SF
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):372-385. PubMed ID: 28122086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Usefulness of oral pilocarpin therapy in the treatment of xerostomia and xerophthalmia in patients with primary Sjögren's syndrome].
    Solans R; Bosch JA; Selva A; Simeón CP; Fonollosa V; Vilardell M
    Med Clin (Barc); 2004 Feb; 122(7):253-5. PubMed ID: 15012873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of topical 0.05 % cyclosporine A in patients with dry eye disease associated with Sjögren's syndrome.
    Devecı H; Kobak S
    Int Ophthalmol; 2014 Oct; 34(5):1043-8. PubMed ID: 24442759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca.
    Friedlaender MH
    Rheum Dis Clin North Am; 1992 Aug; 18(3):591-608. PubMed ID: 1496163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of Carbopol 974P (Siccafluid) in the treatment of severe to moderate keratoconjunctivitis sicca in patients with primary Sjögren's syndrome not responding to standard treatment with artificial tears].
    Ostuni P; Battista ME; Furlan A
    Reumatismo; 2005; 57(2):119-24. PubMed ID: 15983636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
    Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
    Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sjogren's syndrome].
    Rasković S; Bogić M; Perić-Popadić A; Tomić-Spirić V
    Srp Arh Celok Lek; 1997; 125(1-2):54-8. PubMed ID: 17974357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen.
    Dastjerdi MH; Hamrah P; Dana R
    Cornea; 2009 Dec; 28(10):1091-6. PubMed ID: 19770713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
    Hong S; Kim T; Chung SH; Kim EK; Seo KY
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):78-82. PubMed ID: 17341155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A 0,05% cyclosporine treatment of the advanced dry eye syndrome].
    Kujawa A; Rózycki R
    Klin Oczna; 2005; 107(4-6):280-6. PubMed ID: 16118939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conventional therapy of Sjogren's syndrome.
    Mavragani CP; Moutsopoulos HM
    Clin Rev Allergy Immunol; 2007 Jun; 32(3):284-91. PubMed ID: 17992595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops (II) in the Treatment of Dry Eye Associated with Primary Sjögren's Syndrome.
    Gao M; Zhao L; Liang R; Zhu Q; Zhao Q; Kong X
    Ocul Immunol Inflamm; 2023 Oct; 31(8):1662-1668. PubMed ID: 35914303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (types 1 and 2) in the tear film in Sjogren's syndrome and HIV infection.
    Willoughby CE; Baker K; Kaye SB; Carey P; O'Donnell N; Field A; Longman L; Bucknall R; Hart CA
    J Med Virol; 2002 Nov; 68(3):378-83. PubMed ID: 12226825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.